Polyphor Ltd - Product Pipeline Review - 2016

  • ID: 4035457
  • Company Profile
  • 39 pages
  • Global Markets Direct
  • Polyphor Ltd
1 of 4
Polyphor Ltd - Product Pipeline Review - 2016

Summary

‘Polyphor Ltd - Product Pipeline Review - 2016’, provides an overview of the Polyphor Ltd’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Polyphor Ltd, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

This report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope:

- The report provides a snapshot of the pipeline therapeutic landscape of Polyphor Ltd
- The report provides overview of Polyphor Ltd including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Polyphor Ltd’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Polyphor Ltd’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to Buy:

- Evaluate Polyphor Ltd’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Polyphor Ltd
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Polyphor Ltd’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
READ MORE
Note: Product cover images may vary from those shown
2 of 4
Introduction

Polyphor Ltd Snapshot

Polyphor Ltd Overview

Key Facts

Polyphor Ltd - Research and Development Overview

Key Therapeutic Areas

Polyphor Ltd - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Pipeline Products - Partnered Products

Partnered Products/Combination Treatment Modalities

Polyphor Ltd - Pipeline Products Glance

Polyphor Ltd - Clinical Stage Pipeline Products

Phase II Products/Combination Treatment Modalities

Phase I Products/Combination Treatment Modalities

Polyphor Ltd - Early Stage Pipeline Products

Preclinical Products/Combination Treatment Modalities

Discovery Products/Combination Treatment Modalities

Polyphor Ltd - Drug Profiles

balixafortide - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

POL-5551 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

POL-6014 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

POL-6926 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

POL-7001 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

POL-7080 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

POL-7080 Follow-On - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Small Molecules for Unspecified Indication - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Synthetic Peptides for Unspecified Indication - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Synthetic Peptides to Agonize FPR1/2 for Immunology and Infectious Disease - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Synthetic Peptides to Antagonize FPR1/2 for Immunology and Infectious Disease - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Polyphor Ltd - Pipeline Analysis

Polyphor Ltd - Pipeline Products by Target

Polyphor Ltd - Pipeline Products by Route of Administration

Polyphor Ltd - Pipeline Products by Molecule Type

Polyphor Ltd - Pipeline Products by Mechanism of Action

Polyphor Ltd - Dormant Projects

Polyphor Ltd - Discontinued Pipeline Products

Discontinued Pipeline Product Profiles

POL-7080

Polyphor Ltd - Locations And Subsidiaries

Head Office

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables:

Polyphor Ltd, Key Facts

Polyphor Ltd - Pipeline by Indication, 2016

Polyphor Ltd - Pipeline by Stage of Development, 2016

Polyphor Ltd - Monotherapy Products in Pipeline, 2016

Polyphor Ltd - Partnered Products in Pipeline, 2016

Polyphor Ltd - Partnered Products/ Combination Treatment Modalities, 2016

Polyphor Ltd - Phase II, 2016

Polyphor Ltd - Phase I, 2016

Polyphor Ltd - Preclinical, 2016

Polyphor Ltd - Discovery, 2016

Polyphor Ltd - Pipeline by Target, 2016

Polyphor Ltd - Pipeline by Route of Administration, 2016

Polyphor Ltd - Pipeline by Molecule Type, 2016

Polyphor Ltd - Pipeline Products by Mechanism of Action, 2016

Polyphor Ltd - Dormant Developmental Projects,2016

Polyphor Ltd - Discontinued Pipeline Products, 2016

List of Figures:

Polyphor Ltd - Pipeline by Top 10 Indication, 2016

Polyphor Ltd - Pipeline by Stage of Development, 2016

Polyphor Ltd - Monotherapy Products in Pipeline, 2016

Polyphor Ltd - Pipeline by Target, 2016

Polyphor Ltd - Pipeline by Route of Administration, 2016

Polyphor Ltd - Pipeline by Molecule Type, 2016

Polyphor Ltd - Pipeline Products by Mechanism of Action,
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll